Michele Simbolo

Michele Simbolo

Department of Diagnostics and Public Health, University and hospital trust of Verona

Affiliated withUniversity and hospital trust of Verona

Research Area

Biography

Michele Simbolo is a biotechnologist in the Department of Diagnostic and Public Health , University of Verona, Italy. He received his undergraduate degree from University of Naples "Federico II" of Italy, and a Ph.D. from the University of Verona, Italy.

During Dr. Simbolo’s training he developed a keen focus on next generation sequencing technologies, in particular Solid and Ion Torrent platforms. His research was focused on solid tumors genomic characterization. As a post-doctoral fellow (2015 to 2017) in Aldo Scarpa’s lab at the ARC-NET, University of Verona, Italy, he developed new diagnostic tools to identify pancreatic cancer predisposition. He's been hired to University of Verona, Italy, as a laboratory technician. Here he continues the development of new diagnostic tools and the genomic characterization of rare tumors.

JoVE Journal Publications

ArticleTotal : 1
Year
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Publication title
2019

Other Publications

Article
Year
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association| PubMed ID: 24272205

2014
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas.

Virchows Archiv : an international journal of pathology| PubMed ID: 24828033

2014
2014
2014
2015
Next-generation sequencing for genetic testing of familial colorectal cancer syndromes.

Hereditary cancer in clinical practice| PubMed ID: 26300997

2015
2015
New genomic landscapes and therapeutic targets for biliary tract cancers.

Frontiers in bioscience (Landmark edition)| PubMed ID: 26709801

2016
2016
2017
2017
2018
2018
2018
2018
2018
Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer| PubMed ID: 30149143

2018
2018
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine.

Virchows Archiv : an international journal of pathology| PubMed ID: 30219970

2018
2019
2019
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer| PubMed ID: 31085341

2019
Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification?

HPB : the official journal of the International Hepato Pancreato Biliary Association| PubMed ID: 31122820

2019
2019
2019
Glioblastoma with tumor-to-tumor metastasis from lung adenocarcinoma.

Neuropathology : official journal of the Japanese Society of Neuropathology| PubMed ID: 31523853

2019